L. Van-der-hoek, K. Pyrc, M. Jebbink, W. Vermeulen-oost, R. Berkhout et al., Identification of a new human coronavirus, Nature Medicine, vol.10, issue.4, pp.368-73, 2004.
DOI : 10.1038/nm1024

P. Woo, S. Lau, C. Chu, K. Chan, H. Tsoi et al., Characterization and Complete Genome Sequence of a Novel Coronavirus, Coronavirus HKU1, from Patients with Pneumonia, Journal of Virology, vol.79, issue.2, pp.884-95, 2005.
DOI : 10.1128/JVI.79.2.884-895.2005

J. Peiris, Y. Guan, and K. Yuen, Severe acute respiratory syndrome, Nature Medicine, vol.94, issue.12s, pp.88-97, 2004.
DOI : 10.1172/JCI200421328

URL : https://hal.archives-ouvertes.fr/pasteur-00167032

B. Bosch, R. Van-der-zee, C. De-haan, and P. Rottier, The Coronavirus Spike Protein Is a Class I Virus Fusion Protein: Structural and Functional Characterization of the Fusion Core Complex, Journal of Virology, vol.77, issue.16, pp.8801-8812, 2003.
DOI : 10.1128/JVI.77.16.8801-8811.2003

H. Song, M. Seo, K. Stadler, B. Yoo, Q. Choo et al., Synthesis and Characterization of a Native, Oligomeric Form of Recombinant Severe Acute Respiratory Syndrome Coronavirus Spike Glycoprotein, Journal of Virology, vol.78, issue.19, pp.10328-10363, 2004.
DOI : 10.1128/JVI.78.19.10328-10335.2004

W. Li, M. Moore, N. Vasilieva, J. Sui, S. Wong et al., Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus, Nature, vol.426, issue.6965, pp.450-454, 2003.
DOI : 10.1038/nature02145

P. Wang, J. Chen, A. Zheng, Y. Nie, X. Shi et al., Expression cloning of functional receptor used by SARS coronavirus, Biochemical and Biophysical Research Communications, vol.315, issue.2, pp.439-483, 2004.
DOI : 10.1016/j.bbrc.2004.01.076

S. Jeffers, S. Tusell, L. Gillim-ross, E. Hemmila, J. Achenbach et al., CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus, Proceedings of the National Academy of Sciences, vol.101, issue.44, pp.15748-53, 2004.
DOI : 10.1073/pnas.0403812101

Z. Yang, Y. Huang, L. Ganesh, K. Leung, W. Kong et al., pH-Dependent Entry of Severe Acute Respiratory Syndrome Coronavirus Is Mediated by the Spike Glycoprotein and Enhanced by Dendritic Cell Transfer through DC-SIGN, Journal of Virology, vol.78, issue.11, pp.5642-50, 2004.
DOI : 10.1128/JVI.78.11.5642-5650.2004

G. Simmons, J. Reeves, A. Rennekamp, S. Amberg, A. Piefer et al., Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry, Proceedings of the National Academy of Sciences, vol.101, issue.12, pp.4240-4245, 2004.
DOI : 10.1073/pnas.0306446101

H. Hofmann, K. Hattermann, A. Marzi, T. Gramberg, M. Geier et al., S Protein of Severe Acute Respiratory Syndrome-Associated Coronavirus Mediates Entry into Hepatoma Cell Lines and Is Targeted by Neutralizing Antibodies in Infected Patients, Journal of Virology, vol.78, issue.12, pp.6134-6176, 2004.
DOI : 10.1128/JVI.78.12.6134-6142.2004

Y. Nie, G. Wang, X. Shi, H. Zhang, Y. Qiu et al., Neutralizing Antibodies in Patients with Severe Acute Respiratory Syndrome???Associated Coronavirus Infection, The Journal of Infectious Diseases, vol.190, issue.6, pp.1119-1145, 2004.
DOI : 10.1086/423286

T. Greenough, G. Babcock, A. Roberts, H. Hernandez, T. Jr et al., Development and Characterization of a Severe Acute Respiratory Syndrome???Associated Coronavirus???Neutralizing Human Monoclonal Antibody That Provides Effective Immunoprophylaxis in Mice, The Journal of Infectious Diseases, vol.191, issue.4, pp.507-521, 2005.
DOI : 10.1086/427242

J. Ter-meulen, A. Bakker, E. Van-den-brink, G. Weverling, B. Martina et al., Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets, The Lancet, vol.363, issue.9427, pp.2139-2180, 2004.
DOI : 10.1016/S0140-6736(04)16506-9

K. Subbarao, J. Mcauliffe, L. Vogel, G. Fahle, S. Fischer et al., Prior Infection and Passive Transfer of Neutralizing Antibody Prevent Replication of Severe Acute Respiratory Syndrome Coronavirus in the Respiratory Tract of Mice, Journal of Virology, vol.78, issue.7, pp.3572-3579, 2004.
DOI : 10.1128/JVI.78.7.3572-3577.2004

H. Bisht, A. Roberts, L. Vogel, A. Bukreyev, P. Collins et al., Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice, Proceedings of the National Academy of Sciences, vol.101, issue.17, pp.6641-6647, 2004.
DOI : 10.1073/pnas.0401939101

E. Traggiai, S. Becker, K. Subbarao, L. Kolesnikova, Y. Uematsu et al., An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus, Nature Medicine, vol.162, issue.8, pp.871-876, 2004.
DOI : 10.1128/JVI.77.19.10394-10403.2003

J. Sui, W. Li, A. Roberts, L. Matthews, A. Murakami et al., Evaluation of Human Monoclonal Antibody 80R for Immunoprophylaxis of Severe Acute Respiratory Syndrome by an Animal Study, Epitope Mapping, and Analysis of Spike Variants, Journal of Virology, vol.79, issue.10, pp.5900-5906, 2005.
DOI : 10.1128/JVI.79.10.5900-5906.2005

Z. Yang, W. Kong, Y. Huang, A. Roberts, B. Murphy et al., A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice, Nature, vol.428, issue.6982, pp.561-565, 2004.
DOI : 10.1038/nature02463

H. Bisht, A. Roberts, L. Vogel, K. Subbarao, and B. Moss, Neutralizing antibody and protective immunity to SARS coronavirus infection of mice induced by a soluble recombinant polypeptide containing an N-terminal segment of the spike glycoprotein, Virology, vol.334, issue.2, pp.160-165, 2005.
DOI : 10.1016/j.virol.2005.01.042

Z. Zhou, P. Post, R. Chubet, K. Holtz, C. Mcpherson et al., A recombinant baculovirus-expressed S glycoprotein vaccine elicits high titers of SARS-associated coronavirus (SARS-CoV) neutralizing antibodies in mice, Vaccine, vol.24, issue.17, pp.3624-3655, 2006.
DOI : 10.1016/j.vaccine.2006.01.059

R. See, A. Zakhartchouk, M. Petric, D. Lawrence, C. Mok et al., Comparative evaluation of two severe acute respiratory syndrome (SARS) vaccine candidates in mice challenged with SARS coronavirus, Journal of General Virology, vol.87, issue.3
DOI : 10.1099/vir.0.81579-0

E. Qin, H. Shi, L. Tang, C. Wang, G. Chang et al., Immunogenicity and protective efficacy in monkeys of purified inactivated Vero-cell SARS vaccine, Vaccine, vol.24, issue.7, pp.1028-1062, 2006.
DOI : 10.1016/j.vaccine.2005.06.038

H. Weingartl, M. Czub, S. Czub, J. Neufeld, P. Marszal et al., Immunization with Modified Vaccinia Virus Ankara-Based Recombinant Vaccine against Severe Acute Respiratory Syndrome Is Associated with Enhanced Hepatitis in Ferrets, Journal of Virology, vol.78, issue.22, pp.12672-12678, 2004.
DOI : 10.1128/JVI.78.22.12672-12676.2004

Z. Yang, H. Werner, W. Kong, K. Leung, E. Traggiai et al., Evasion of antibody neutralization in emerging severe acute respiratory syndrome coronaviruses, Proceedings of the National Academy of Sciences, vol.102, issue.3, pp.797-801, 2005.
DOI : 10.1073/pnas.0409065102

H. Vennema, R. De-groot, D. Harbour, M. Dalderup, T. Gruffydd-jones et al., Early death after feline infectious peritonitis virus challenge due to recombinant vaccinia virus immunization, J Virol, vol.64, issue.3, pp.1407-1416, 1990.

C. Olsen, W. Corapi, C. Ngichabe, J. Baines, and F. Scott, Monoclonal antibodies to the spike protein of feline infectious peritonitis virus mediate antibody-dependent enhancement of infection of feline macrophages, J Virol, vol.66, issue.2, pp.956-65, 1992.

B. Martina, B. Haagmans, T. Kuiken, R. Fouchier, G. Rimmelzwaan et al., Virology: SARS virus infection of cats and ferrets, Nature, vol.425, issue.6961, p.915, 2003.
DOI : 10.1038/425915a

R. Fouchier, T. Kuiken, M. Schutten, G. Van-amerongen, G. Van-doornum et al., Aetiology: Koch's postulates fulfilled for SARS virus, Nature, vol.78, issue.6937, p.240, 2003.
DOI : 10.1038/89098

A. Roberts, L. Vogel, J. Guarner, N. Hayes, B. Murphy et al., Severe Acute Respiratory Syndrome Coronavirus Infection of Golden Syrian Hamsters, Journal of Virology, vol.79, issue.1, pp.503-514, 2005.
DOI : 10.1128/JVI.79.1.503-511.2005

P. Lozach, H. Lortat-jacob, A. De-lacroix-de-lavalette, I. Staropoli, S. Foung et al., DC-SIGN and L-SIGN Are High Affinity Binding Receptors for Hepatitis C Virus Glycoprotein E2, Journal of Biological Chemistry, vol.278, issue.22, pp.20358-66, 2003.
DOI : 10.1074/jbc.M301284200

URL : https://hal.archives-ouvertes.fr/hal-01061433

I. Staropoli, C. Chanel, M. Girard, and R. Altmeyer, Processing, Stability, and Receptor Binding Properties of Oligomeric Envelope Glycoprotein from a Primary HIV-1 Isolate, Journal of Biological Chemistry, vol.275, issue.45, pp.35137-35182, 2000.
DOI : 10.1074/jbc.M003868200

B. Nal, C. Chan, F. Kien, L. Siu, J. Tse et al., Differential maturation and subcellular localization of severe acute respiratory syndrome coronavirus surface proteins S, M and E, Journal of General Virology, vol.86, issue.5, pp.1423-1457, 2005.
DOI : 10.1099/vir.0.80671-0

N. Matoba, A. Magerus, B. Geyer, Y. Zhang, M. Muralidharan et al., A mucosally targeted subunit vaccine candidate eliciting HIV-1 transcytosis-blocking Abs, Proceedings of the National Academy of Sciences, vol.101, issue.37, pp.13584-13593, 2004.
DOI : 10.1073/pnas.0405297101

H. Wu and M. Russell, Induction of mucosal and systemic immune responses by intranasal immunization using recombinant cholera toxin B subunit as an adjuvant, Vaccine, vol.16, issue.2-3, pp.2-3286, 1998.
DOI : 10.1016/S0264-410X(97)00168-0

L. Reed and H. Munich, A simple method for estimating fifty percent endpoints, Am J Hyg, vol.27, pp.493-500, 1938.

P. Lozach, A. A. Bartosch, B. Virelizier, J. Arenzana-seisdedos, F. Cosset et al., C-type Lectins L-SIGN and DC-SIGN Capture and Transmit Infectious Hepatitis C Virus Pseudotype Particles, Journal of Biological Chemistry, vol.279, issue.31, pp.32035-32080, 2004.
DOI : 10.1074/jbc.M402296200

X. Shi, E. Gong, D. Gao, B. Zhang, J. Zheng et al., Severe Acute Respiratory Syndrome Associated Coronavirus Is Detected in Intestinal Tissues of Fatal Cases, The American Journal of Gastroenterology, vol.42, issue.1, pp.169-76, 2005.
DOI : 10.1016/S0006-2952(02)01121-8

K. Reddin, T. Easterbrook, S. Eley, P. Russell, V. Mobsby et al., Comparison of the immunological and protective responses elicited by microencapsulated formulations of the F1 antigen from Yersinia pestis, Vaccine, vol.16, issue.8, pp.761-768, 1998.
DOI : 10.1016/S0264-410X(97)00305-8

N. Gomez, C. Carrillo, J. Salinas, F. Parra, M. Borca et al., Expression of Immunogenic Glycoprotein S Polypeptides from Transmissible Gastroenteritis Coronavirus in Transgenic Plants, Virology, vol.249, issue.2, pp.352-360, 1998.
DOI : 10.1006/viro.1998.9315

Y. He, Y. Zhou, S. Liu, Z. Kou, W. Li et al., Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine, Biochemical and Biophysical Research Communications, vol.324, issue.2, pp.773-81, 2004.
DOI : 10.1016/j.bbrc.2004.09.106

I. Anton, S. Gonzalez, M. Bullido, M. Corsin, C. Risco et al., Cooperation between transmissible gastroenteritis coronavirus (TGEV) structural proteins in the in vitro induction of virus-specific antibodies, Virus Research, vol.46, issue.1-2, pp.111-135, 1996.
DOI : 10.1016/S0168-1702(96)01390-1

B. Delmas and H. Laude, Assembly of coronavirus spike protein into trimers and its role in epitope expression, J Virol, vol.64, issue.11, pp.5367-75, 1990.

R. Gupta and G. Siber, Adjuvants for human vaccines???current status, problems and future prospects, Vaccine, vol.13, issue.14, pp.1263-76, 1995.
DOI : 10.1016/0264-410X(95)00011-O

F. Van-ginkel, H. Nguyen, and J. Mcghee, Vaccines for Mucosal Immunity to Combat Emerging Infectious Diseases, Emerging Infectious Diseases, vol.6, issue.2, pp.123-155, 2000.
DOI : 10.3201/eid0602.000204

J. Lee, H. Poo, D. Han, S. Hong, K. Kim et al., Mucosal Immunization with Surface-Displayed Severe Acute Respiratory Syndrome Coronavirus Spike Protein on Lactobacillus casei Induces Neutralizing Antibodies in Mice, Journal of Virology, vol.80, issue.8, pp.4079-87, 2006.
DOI : 10.1128/JVI.80.8.4079-4087.2006

K. Renegar, S. Jr, P. Boykins, L. Wright, and P. , Role of IgA versus IgG in the Control of Influenza Viral Infection in the Murine Respiratory Tract, The Journal of Immunology, vol.173, issue.3, pp.1978-86, 2004.
DOI : 10.4049/jimmunol.173.3.1978

Y. He, H. Lu, P. Siddiqui, Y. Zhou, and S. Jiang, Receptor-Binding Domain of Severe Acute Respiratory Syndrome Coronavirus Spike Protein Contains Multiple Conformation-Dependent Epitopes that Induce Highly Potent Neutralizing Antibodies, The Journal of Immunology, vol.174, issue.8, pp.4908-4923, 2005.
DOI : 10.4049/jimmunol.174.8.4908

Y. He, Q. Zhu, S. Liu, Y. Zhou, Y. B. Li et al., Identification of a critical neutralization determinant of severe acute respiratory syndrome (SARS)-associated coronavirus: importance for designing SARS vaccines, Virology, vol.334, issue.1, pp.74-82, 2005.
DOI : 10.1016/j.virol.2005.01.034

J. Sui, W. Li, A. Murakami, A. Tamin, L. Matthews et al., Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association, Proceedings of the National Academy of Sciences, vol.101, issue.8, pp.2536-2577, 2004.
DOI : 10.1073/pnas.0307140101

H. Zhang, G. Wang, J. Li, Y. Nie, X. Shi et al., Identification of an Antigenic Determinant on the S2 Domain of the Severe Acute Respiratory Syndrome Coronavirus Spike Glycoprotein Capable of Inducing Neutralizing Antibodies, Journal of Virology, vol.78, issue.13, pp.6938-6983, 2004.
DOI : 10.1128/JVI.78.13.6938-6945.2004

S. Halstead, Neutralization and Antibody-Dependent Enhancement of Dengue Viruses, Adv Virus Res, vol.60, pp.421-67, 2003.
DOI : 10.1016/S0065-3527(03)60011-4

S. Halstead, H. Shotwell, and J. Casals, Studies on the Pathogenesis of Dengue Infection in Monkeys. II. Clinical Laboratory Responses to Heterologous Infection, Journal of Infectious Diseases, vol.128, issue.1, pp.15-22, 1973.
DOI : 10.1093/infdis/128.1.15

G. Fust, Enhancing antibodies in HIV infection, Parasitology, vol.115, issue.7, pp.127-167, 1997.
DOI : 10.1017/S0031182097001819

A. Takada, S. Watanabe, K. Okazaki, H. Kida, and Y. Kawaoka, Infectivity-Enhancing Antibodies to Ebola Virus Glycoprotein, Journal of Virology, vol.75, issue.5, pp.2324-2354, 2001.
DOI : 10.1128/JVI.75.5.2324-2330.2001

A. Takada and Y. Kawaoka, Antibody-dependent enhancement of viral infection: molecular mechanisms andin vivo implications, Reviews in Medical Virology, vol.10, issue.6, pp.387-98, 2003.
DOI : 10.1002/rmv.405

F. Yuan, J. Tanner, P. Chan, S. Biffin, W. Dyer et al., Influence of FcgammaRIIA and MBL polymorphisms on severe acute respiratory syndrome, Tissue Antigens, vol.9, issue.4, pp.291-297, 2005.
DOI : 10.1086/429631

G. Simmons, D. Gosalia, A. Rennekamp, J. Reeves, S. Diamond et al., Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry, Proceedings of the National Academy of Sciences, vol.102, issue.33, pp.11876-81, 2005.
DOI : 10.1073/pnas.0505577102

S. Matsuyama, M. Ujike, S. Morikawa, M. Tashiro, and F. Taguchi, Protease-mediated enhancement of severe acute respiratory syndrome coronavirus infection, Proceedings of the National Academy of Sciences, vol.102, issue.35, pp.12543-12550, 2005.
DOI : 10.1073/pnas.0503203102

B. Bosch, B. Martina, R. Van-der-zee, J. Lepault, B. Haijema et al., Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides, Proceedings of the National Academy of Sciences, vol.101, issue.22, pp.8455-60, 2004.
DOI : 10.1073/pnas.0400576101

C. Olsen, W. Corapi, R. Jacobson, R. Simkins, L. Saif et al., Identification of antigenic sites mediating antibody-dependent enhancement of feline infectious peritonitis virus infectivity, Journal of General Virology, vol.74, issue.4, pp.745-754, 1993.
DOI : 10.1099/0022-1317-74-4-745

W. Corapi, R. Darteil, J. Audonnet, and G. Chappuis, Localization of antigenic sites of the S glycoprotein of feline infectious peritonitis virus involved in neutralization and antibody-dependent enhancement, J Virol, vol.69, issue.5, pp.2858-62, 1995.

M. Daeron, Structural Bases of Fc??R Functions, International Reviews of Immunology, vol.139, issue.1-2, pp.1-27, 1997.
DOI : 10.1172/JCI118420

J. Gu, E. Gong, B. Zhang, J. Zheng, Z. Gao et al., Multiple organ infection and the pathogenesis of SARS, The Journal of Experimental Medicine, vol.10, issue.3, pp.415-439, 2005.
DOI : 10.1038/sj.cr.7290158

K. Stadler, A. Roberts, S. Becker, L. Vogel, M. Eickmann et al., SARS Vaccine Protective in Mice, Emerging Infectious Diseases, vol.11, issue.8, pp.1312-1316, 2005.
DOI : 10.3201/eid1108.041003